Merck announces completion of Acceleron Pharma acquisition - NewsBreak

Following a deal first announced in September, Merck (NYSE:MRK) says it has successfully completed the acquisition of Acceleron Pharma (NASDAQ:XLRN). "This is an important and strategic opportunity for our company to continue growing our cardiovascular portfolio and pipeline, that...